Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of Minnesota |
---|---|
Information provided by: | University of Minnesota |
ClinicalTrials.gov Identifier: | NCT00830375 |
This is an 8-week, open-labe study of memantine in the treatment of compulsive buying.
Condition | Intervention | Phase |
---|---|---|
Compulsive Buying |
Drug: Memantine |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Dose Comparison, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Memantine Treatment of Compulsive Buying: An Open-Label Study |
Estimated Enrollment: | 16 |
Study Start Date: | December 2008 |
Estimated Study Completion Date: | November 2009 |
Estimated Primary Completion Date: | October 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Memantine: Experimental
10-30mg, memantine
|
Drug: Memantine
10-30mg, by mouth, daily
|
The goal of the proposed study is to evaluate the efficacy of memantine in the treatment of compulsive buying. Sixteen subjects meeting criteria for compulsive buying will receive 8 weeks of open-label memantine. The hypothesis to be tested is that memantine will be effective and well tolerated in patients with compulsive buying. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Brian Odlaug, BA | 612-627-4363 | odla0019@umn.edu |
Contact: Jon Grant, MD | 612-273-9736 | grant045@umn.edu |
United States, Minnesota | |
University of Minnesota | Recruiting |
Minneapolis, Minnesota, United States, 55454 | |
Contact: Brian Odlaug, BA 612-627-4363 odla0019@umn.edu | |
Contact: Jon Grant, MD 612-273-9736 grant045@umn.edu | |
Principal Investigator: Jon Grant, MD | |
Sub-Investigator: SW Kim, MD | |
Ambulatory Research Center | Recruiting |
Minneapolis, Minnesota, United States, 55454 | |
Contact: Brian L Odlaug, B.A. 612-627-4363 odla0019@umn.edu | |
Principal Investigator: Jon E Grant, M.D. |
Principal Investigator: | Jon Grant, MD | University of Minnesota |
Responsible Party: | University of Minnes0ta ( Jon E. Grant, MD ) |
Study ID Numbers: | 0806M37821 |
Study First Received: | January 23, 2009 |
Last Updated: | March 16, 2009 |
ClinicalTrials.gov Identifier: | NCT00830375 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Buying Shopping Impulse Control |
Excitatory Amino Acids Neurotransmitter Agents Dopamine Memantine Dopamine Agents |
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Anti-Dyskinesia Agents Therapeutic Uses Physiological Effects of Drugs Antiparkinson Agents |
Memantine Excitatory Amino Acid Agents Dopamine Agents Central Nervous System Agents Pharmacologic Actions Excitatory Amino Acid Antagonists |